Guardant Health (GH) Depreciation & Amortization (CF) (2017 - 2026)

Guardant Health has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $9.6 million in Q2 2026.

• Quarterly Depreciation & Amortization (CF) fell 4.79% year-over-year to $9.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $38.5 million (down 6.94% YoY) and the FY2025 annual result came in at $39.7 million, down 6.25% from the prior year.
• Depreciation & Amortization (CF) grew to $9.6 million in Q2 2026 per GH's latest filing, from $9.4 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $11.0 million in Q3 2023 and troughed at $7.2 million in Q1 2022.
• A 5-year average of $10.0 million and a median of $10.2 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 76.89% in 2022, then retreated 11.23% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $10.2 million in 2022, then grew by 6.87% to $10.9 million in 2023, then dropped by 3.81% to $10.5 million in 2024, then slipped by 3.86% to $10.0 million in 2025, then decreased by 4.87% to $9.6 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $9.6 million, $9.4 million, and $10.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.